Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620000384954
Ethics application status
Approved
Date submitted
5/03/2020
Date registered
20/03/2020
Date last updated
23/04/2021
Date data sharing statement initially provided
20/03/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
Evaluation of healthy adults' views on the value of different educational tools for skin cancer early detection
Scientific title
Evaluation of healthy adults' views on the value of different educational tools for skin cancer early detection - a qualitative study
Secondary ID [1] 300494 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Skin cancer 316174 0
Skin self-examination 316190 0
Condition category
Condition code
Cancer 314468 314468 0 0
Malignant melanoma
Cancer 314469 314469 0 0
Non melanoma skin cancer
Public Health 314482 314482 0 0
Health promotion/education

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
The Skin Cancer College of Australasia has compiled a new proposed mnemonic entitled SCAN (Sore, Changing, Abnormal, New) for skin self-examination. This educational tool was developed to help individuals estimate their risk and recognise the early signs of skin cancer. The objective of this study is to undertake a qualitative investigation on satisfaction with the SCAN rule in comparison to other well known skin self examination tools for skin cancer early detection.

We aim to conduct focus groups, with each participant to only attend one focus group. The focus groups will be held in person at the Translational Research Institute, Woolloongabba, Brisbane. Approximately, 6-8 participants will be invited to attend each group and will last approximately 60 minutes. After providing written consent, participants will be asked to complete a short survey assessing basic demographics, skin cancer history and previous skin checking habits at the start of the focus group. The facilitator will follow a semi-structured format and follow the discussion guide. Topics in the discussion guide include self-examination practices, use of education tools for skin self-examination and the use of pictures to optimise understanding.

The assistant facilitator will audio record the focus group and takes notes.

Intervention code [1] 316803 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 322797 0
Satisfaction with the skin self-examination mnemonics as assessed by content analysis of recorded focus groups
Timepoint [1] 322797 0
Once-off focus group
Primary outcome [2] 323185 0
Skin self-examination practices as assessed by content analysis of recorded focus groups
Timepoint [2] 323185 0
Once-off focus group
Secondary outcome [1] 379827 0
Not applicable
Timepoint [1] 379827 0
Not applicable

Eligibility
Key inclusion criteria
Be 18 years of age and over; and understand sufficient English,
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
No exclusion criteria

Study design
Purpose
Duration
Cross-sectional
Selection
Convenience sample
Timing
Prospective
Statistical methods / analysis
After each focus group, the facilitator and the assistant will debrief to document observations about focus group processes, dynamics, content and initially emerging patterns. The qualitative data will be analysed using content analysis by following a process of searching text, for recurring words, concepts or ideas.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
30/03/2020
Actual
30/03/2020
Date of last participant enrolment
Anticipated
27/04/2020
Actual
25/05/2020
Date of last data collection
Anticipated
4/05/2020
Actual
25/05/2020
Sample size
Target
20
Accrual to date
Final
28
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment postcode(s) [1] 29274 0
4102 - Woolloongabba

Funding & Sponsors
Funding source category [1] 304911 0
Commercial sector/Industry
Name [1] 304911 0
Skin Cancer College Australasia
Country [1] 304911 0
Australia
Primary sponsor type
University
Name
University of Queensland - Centre for Health Services Research
Address
The University of Queenland,
Level 2, Building 33,
Princess Alexandra Hospital
Woolloongabba QLD 4102
Country
Australia
Secondary sponsor category [1] 305259 0
None
Name [1] 305259 0
Address [1] 305259 0
Country [1] 305259 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 305320 0
University of Queensland Human Research Ethics Committee
Ethics committee address [1] 305320 0
Ethics committee country [1] 305320 0
Australia
Date submitted for ethics approval [1] 305320 0
31/01/2020
Approval date [1] 305320 0
25/02/2020
Ethics approval number [1] 305320 0
2020000146

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 99986 0
Prof Monika Janda
Address 99986 0
The University of Queensland
Level 2, Building 33,
Princess Alexandra Hospital
Woolloongabba Qld 4102
Country 99986 0
Australia
Phone 99986 0
+61 731764569
Fax 99986 0
Email 99986 0
[email protected]
Contact person for public queries
Name 99987 0
Monika Janda
Address 99987 0
The University of Queensland
Level 2, Building 33,
Princess Alexandra Hospital
Woolloongabba Qld 4102
Country 99987 0
Australia
Phone 99987 0
+61 731764569
Fax 99987 0
Email 99987 0
[email protected]
Contact person for scientific queries
Name 99988 0
Monika Janda
Address 99988 0
The University of Queensland
Level 2, Building 33,
Princess Alexandra Hospital
Woolloongabba Qld 4102
Country 99988 0
Australia
Phone 99988 0
+61 731764569
Fax 99988 0
Email 99988 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.